Clinical Study

Interleukin 18 as a Marker of Chronic Nephropathy in Children after Anticancer Treatment

Table 1

Connections between time of followup and signs of nephropathy, and glomerulopathy, tubulopathy.

NephropathyGlomerulopathyTubulopathy
YesNo YesNo YesNo

Time to followup
(median of years; quartiles)
4.03 (2.34–7.17) 5.17 (3.67–7.38) 0.07864.63 (2.59–8.12)4.42 (3.25–6.08)0.8889 3.43 (1.79–4.97)5.13 (3.48–4.97)0.0039